Lipophilicity and hydrophobicity considerations in bio-enabling oral formulations approaches – a PEARRL review

MLA

Ditzinger, F.Price, D. J.Ilie, A. R.Köhl, N. J.Jankovic, S.Tsakiridou, G.Aleandri, S.Kalantzi, L.Holm, R.Nair, A.Saal, C.Griffin, B.Kuentz, M. Lipophilicity and Hydrophobicity Considerations in Bio-Enabling Oral Formulations Approaches – a PEARRL Review. Jan. 2019. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.od......2127..32de8a2107f66c037040e88cb24a455e&authtype=sso&custid=ns315887.

APA

Ditzinger, F. P. D. J. I. A.-R. K. N. J. J. S. T. G. A. S. K. L. H. R. N. A. S. C. G. B. K. M. (2019). Lipophilicity and hydrophobicity considerations in bio-enabling oral formulations approaches – a PEARRL review.

Chicago

Ditzinger, F. Price, D.J. Ilie, A.-R. Köhl, N.J. Jankovic, S. Tsakiridou, G. Aleandri, S. Kalantzi, L. Holm, R. Nair, A. Saal, C. Griffin, B. Kuentz, M. 2019. “Lipophilicity and Hydrophobicity Considerations in Bio-Enabling Oral Formulations Approaches – a PEARRL Review,” January. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.od......2127..32de8a2107f66c037040e88cb24a455e&authtype=sso&custid=ns315887.